{
  "id": 18097988,
  "title": "Aarti Drugs Q2 FY27 Earnings Shine As Profit Nearly Doubles To ₹82.8 Crore, Revenue Rises 27% To ₹828.8 Crore While 63% EBITDA Growth Signals Stronger Operating Performance",
  "url": "https://urgent.news/2026/11/04/aarti-drugs-q2-fy27-earnings-shine-as-profit-nearly-doubles-to-82-8",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-04T07:59:35.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/aarti-drugs-q2-fy27-earnings-shine-as-profit-nearly-doubles-to-828-crore-revenue-rises-27-to-8288-crore-while-63-ebitda-growth-signals-stronger-operating-performance"
  },
  "original_language": "en",
  "account": null,
  "summary": "Mumbai: Aarti Drugs reported strong financial results for the second quarter of FY27, with profit after tax (PAT) rising approximately 83 per cent year-on-year to ₹82.8 crore, compared with ₹45.2 crore in the corresponding quarter last year. Revenue from operations increased 27 per cent to ₹828.8 crore during the July-September quarter, against ₹652.9 crore in Q2 FY26. The pharmaceutical company…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}